Glucose for the management of procedural pain in neonates

  • Protocol
  • Intervention

Authors

  • Mary-Ellen Hogan,

    1. University of Toronto, Graduate Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, Toronto, Ontario, Canada
    Search for more papers by this author
  • Vibhuti S Shah,

    1. University of Toronto, Associate Professor, Departments of Paediatrics and Health Policy, Management and Evaluation, Toronto, Ontario, Canada
    Search for more papers by this author
  • Ryan W Smith,

    1. University of Toronto, Graduate Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, Toronto, Ontario, Canada
    Search for more papers by this author
  • Ashley Yiu,

    1. University of Toronto, Leslie Dan Faculty of Pharmacy, Toronto, Ontario, Canada
    Search for more papers by this author
  • Anna Taddio

    Corresponding author
    1. Hospital for Sick Children Research Institute, Graduate Department of Pharmaceutical Sciences, Toronto, Ontario, Canada
    • Anna Taddio, Graduate Department of Pharmaceutical Sciences, Hospital for Sick Children Research Institute, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada. anna.taddio@sickkids.ca.

    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

Primary objective:

  • to assess the effectiveness of glucose in preterm and full term neonates undergoing skin-breaking procedures, including heel lance, venipuncture, arterial puncture, central line placement, lumbar puncture, suprapubic aspiration, intramuscular or subcutaneous immunization, or other injections.

Secondary objective:

  • to assess the safety of glucose in preterm and full term neonates undergoing skin-breaking procedures.

Ancillary